CAMBRIDGE, Mass., July 28, 2010 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will report its financial results for the second quarter ended June 30, 2010 before the U.S. financial markets open on Monday, August 2, 2010.
